Prevalence of Common HFE and SERPINA1 Mutations in Patients with Hepatocellular Carcinoma in a Moroccan Population

Archives of Medical Research

Volumn 39, Issue 2, 2008, Pages 236-241

  Ezzikouri, Sayeh ^a   El Feydi, Abdellah Essaid ^b   El Kihal, Latifa ^b   Afifi, Rajae ^b   Benazzouz, Mustapha ^b   Hassar, Mohammed ^a   Chafik, Abdelaziz ^c   Pineau, Pascal ^d   Benjelloun, Soumaya ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b IBN SINA HOSPITAL   (Morocco)

^c FACULTÉ DES SCIENCES   (Morocco)

^d INSTITUT PASTEUR   (France)

Author keywords

Hepatocellular carcinoma; HFE mutations; S mutation; Z mutation

Indexed keywords

ALPHA 1 ANTITRYPSIN; DNA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; HEMOCHROMATOSIS; HFE GENE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOROCCO; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERPINA1 GENE;

AGED; ALLELES; ALPHA 1-ANTITRYPSIN; ARABS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOROCCO; MUTATION, MISSENSE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 37349103378     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.09.006     Document Type: Article

References (38)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2 (2001) 533-543
2. Martinez di Montemuros F., Tavazzi D., Salsano E., Piepoli T., Pollo B., Fiorelli G., et al. High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas. Neurology 57 (2001) 1342
3. Gunel-Ozcan A., Alyilmaz-Bekmez S., Guler E.N., and Guc D. HFE H63D mutation frequency shows an increase in Turkish women with breast cancer. BMC Cancer 6 (2006) 37
4. Rudnick D.A., and Perlmutter D.H. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 42 (2005) 514-521
5. Simon M., Le Mignon L., Fauchet R., Yaouanq J., David V., Edan G., et al. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 41 (1987) 89-105
6. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
7. Hanson E.H., Imperatore G., and Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 154 (2001) 193-206
8. Gochee P.A., Powell L.W., Cullen D.J., Du Sart D., Rossi E., and Olynyk J.K. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 122 (2002) 646-651
9. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., and Robson K.J. Global prevalence of putative haemochromatosis mutations. J Med Genet 34 (1997) 275-278
10. De Gobbi M., D'Antico S., Castagno F., Testa D., Merlini R., Bondi A., et al. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. Haematologica 89 (2004) 1161-1167
11. Aguilar-Martinez P., Bismuth M., Picot M.C., Thelcide C., Pageaux G.P., Blanc F., et al. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?. Gut 48 (2001) 836-842
12. Brantly M.L., Paul L.D., Miller B.H., Falk R.T., Wu M., and Crystal R.G. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 138 (1988) 327-336
13. Eriksson S., Carlson J., and Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 314 (1986) 736-739
14. Huber R., and Carell R.W. Implication of the three-dimensional structure of α1-antitrypsin for structure and functions of serpins. Biochemistry 28 (1990) 8951-8966
15. Byth B.C., Billingsley G.D., and Cox D.W. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency. Am J Hum Genet 55 (1994) 126-133
16. Crystal R.G., Brantly M.L., Hubbard R.C., Curiel D.T., States D.J., and Holmes M.D. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest 95 (1989) 196-208
17. Brantly M., Nukiwa T., and Crystal R.G. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 84 (1988) 13-31
18. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 132 (1985) 417-433
19. Aguilar-Martinez P., Picot M.C., Becker F., Boulot P., Montoya F., Mares P., et al. Prevalence of HFE mutations in people from North Africa living in southern France. Br J Haematol 114 (2001) 914-916
20. Zorai A., Harteveld C.L., Rachdi R., Dellagi K., Abbes S., Delbini P., et al. Frequency and spectrum of hemochromatosis mutations in Tunisia. Hematol J 4 (2003) 433-435
21. Koeken A., Cobbaert C., Quint W., and Van Doorn L.J. Genotyping of hemochromatosis-associated mutations in the HFE gene by PCR-RFLP and a novel reverse hybridization method. Clin Chem Lab Med 40 (2002) 122-125
22. Zuntar I., Topic E., Jurcic Z., and Zubcic A. Genotyping of alpha-antitrypsin in ten Croatian families. Clin Biochem 33 (2000) 377-382
23. Valenti L., Dongiovanni P., Piperno A., Fracanzani A.L., Maggioni M., Rametta R., et al. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Hepatology 44 (2006) 857-864
24. Roth M., Giraldo P., Hariti G., Poloni E.S., Sanchez-Mazas A., Stefano G.F., et al. Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics 46 (1997) 222-225
25. Sassi R., Hmida S., Kaabi H., Hajjej A., Abid A., Abdelkefi S., et al. Prevalence of C282Y and H63D mutations in the haemochromatosis (HFE) gene in Tunisian population. Ann Genet 47 (2004) 325-330
26. Sanchez M., Bruguera M., Bosch J., Rodes J., Ballesta F., and Oliva R. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 29 (1998) 725-728
27. Bauduer F., Scribans C., Degioanni A., Renoux M., and Dutour O. Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque Country. Ann Hematol 84 (2005) 99-102
28. Acton R.T., Barton J.C., Snively B.M., McLaren C.E., Adams P.C., Harris E.L., et al. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis 16 (2006) 815-821
29. de Serres F.J. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 122 (2002) 1818-1829
30. Miravitlles M. Alpha1-antitrypsin deficiency: epidemiology and prevalence. Respir Med 94 Suppl C (2000) S12-S15
31. Fargion S., Stazi M.A., Fracanzani A.L., Mattioli M., Sampietro M., Tavazzi D., et al. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma. Blood Cells Mol Dis 27 (2001) 505-511
32. Racchi O., Mangerini R., Rapezzi D., Gaetani G.F., Nobile M.T., Picciotto A., et al. Mutations of the HFE gene and the risk of hepatocellular carcinoma. Blood Cells Mol Dis 25 (1999) 350-353
33. Hellerbrand C., Poppl A., Hartmann A., Scholmerich J., and Lock G. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. Clin Gastroenterol Hepatol 1 (2003) 279-284
34. Fracanzani A.L., Fargion S., Stazi M.A., Valenti L., Amoroso P., Cariani E., et al. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma. Blood Cells Mol Dis 35 (2005) 27-32
35. McGlynn K.A., and London W.T. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19 (2005) 3-23
36. Pirisi M., Toniutto P., Uzzau A., Fabris C., Avellini C., Scott C., et al. Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients. Cancer 89 (2000) 297-302
37. Boige V., Castera L., de Roux N., Ganne-Carrie N., Ducot B., Pelletier G., et al. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis. Gut 52 (2003) 1178-1181
38. Sveger T. The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand 77 (1988) 847-851